Ignipod 200 Tablet contains Cefpodoxime Proxetil 200mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea caused by susceptible strains. Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The prodrug is rapidly absorbed and converted to the active form, cefpodoxime, ensuring effective systemic antibacterial activity. Ignipod 200 is generally well-tolerated; common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be individualized based on infection severity, patient age, and renal function, with typical adult dosing ranging from 100mg to 200mg twice daily. It is essential to complete the full prescribed course to prevent resistance development. Caution is advised in patients with renal impairment, and concurrent use with nephrotoxic drugs should be monitored. Ignipod 200 Tablet should be stored in a cool, dry place away from direct sunlight and out of reach of children. Always consult a healthcare professional before initiating therapy.